Published on December 14, 2023
Exhibit 107
Calculation of Filing Fee Table
Form S-1
(Form Type)
TELOMIR PHARMACEUTICALS, INC.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
Security Type | Security Class Title | Fee Calculation or Carry Forward Rule | Maximum Aggregate Offering Price (1)(2) |
Fee Rate |
Amount of Registration Fee | |||||||||||||
Fees Previously Paid | Equity | Common stock, no par value (3) | 457(o) | $ | 13,800,000 | 0.00014760 | $ | 2,037 | ||||||||||
Equity | Underwriter Warrants (4) | 457(g) | — | — | — | |||||||||||||
Fees Previously Paid | Equity | Common stock issuable upon exercise of Underwriter Warrants (5) | 457(o) | 600,000 | 0.00014760 | 89 | ||||||||||||
Secondary Offering | Equity | Common stock, no par value | 43,500,000 | 0.00014760 | 6,421 | |||||||||||||
Total Offering Amounts | $ | 57,900,000 | $ | 8,547 | ||||||||||||||
Total Fees Previously Paid | $ | 2,126 | ||||||||||||||||
Total Fee Offsets | $ | — | ||||||||||||||||
Net Fee Due | $ | 6,421 |
(1) | Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(o) of the Securities Act of 1933, as amended. Includes shares to be sold upon exercise of the underwriters’ option to purchase additional shares. | |
(2) | Pursuant to Rule 416, the securities being registered hereunder include such indeterminate number of additional securities as may be issued after the date hereof as a result of stock splits, stock dividends or similar transactions. | |
(3) | Includes shares of common stock which may be issued on exercise of a 45-day option granted to the underwriters to cover over-allotments. | |
(4) | No fee pursuant to Rule 457(g) under the Securities Act of 1933, as amended. | |
(5) | As estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(o), the proposed maximum aggregate offering price of the Underwriter Warrants is $833,333, which is equal to 5.0% of the aggregate number of shares of common stock sold in this offering, excluding the overallotment option, at an exercise price equal to 100% of the public offering price per share. |